Evaluation of Posaconazole for Primary Prophylaxis of IFI in Acute Myeloid Leukemia under Intensive Induction Chemotherapy. Comparative Real Life Study with Fluconazole in two Hematological Centers in Algeri
Introduction: Acute myeloid leukemia (AML) is a hematological malignancy with a poor prognosis. The early consequences of induction chemotherapy are represented by pancytopenia with severe immunosuppression, which favors the emergence of so-called “opportunistic” infections and in particular invasiv...
Main Authors: | Mohamed Amine Bekadja, Mauricette Michallet, Brahim Benzineb, Naima Mesli, Hafida Ouldjeriouat, Faiza Serradj, Mohamed Brahimi, Nabil Yafour |
---|---|
Format: | Article |
Language: | English |
Published: |
West Asia Organization for Cancer Prevention
2021-12-01
|
Series: | Asian Pacific Journal of Cancer Biology |
Subjects: | |
Online Access: | http://www.waocp.com/journal/index.php/apjcb/article/view/680 |
Similar Items
-
THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: G. A. Klyasova, et al.
Published: (2017-11-01) -
Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01) -
Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al. -
Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01) -
Posaconazole-induced Glucocorticoid Deficiency in a Patient with Myelodysplastic syndrome.
by: Antonia Precali, et al.
Published: (2023-01-01)